AbbVie Inc.

ABBV | NYSE

Price Alert Chart Builder DCF Calculator

$266.02

+$1.54 (+0.58%)

Sep 22, 2026, 12:47 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	16.99B	15B	16.62B	15.78B	15.42B	13.34B	15.1B	14.46B	14.46B	12.31B	14.3B	13.93B	13.87B	12.23B	15.12B	14.81B	14.58B	13.54B	14.89B	14.34B	13.96B	13.01B
Cost of Revenue	4.29B	4.22B	4.55B	5.3B	4.35B	4B	4.4B	4.21B	4.2B	4.09B	5.7B	6.49B	4.24B	3.99B	4.17B	5.02B	4.17B	4.05B	4.32B	4.39B	4.52B	4.21B
Gross Profit	12.7B	10.78B	12.07B	10.47B	11.08B	9.34B	10.71B	10.25B	10.26B	8.22B	8.6B	7.44B	9.63B	8.24B	10.95B	9.79B	10.41B	9.49B	10.57B	9.95B	9.44B	8.8B
Operating Income	6.43B	4.73B	5.81B	1.9B	4.89B	3.73B	-1.49B	3.83B	4B	2.8B	3.2B	2.28B	4.51B	2.77B	5.5B	4.6B	3.3B	4.72B	5.07B	4.31B	4.44B	4.1B
Interest Income	67M	72M	59M	72M	62M	73M	92M	129M	220M	207M	186M	157M	98M	99M	90M	63M	24M	9M	9M	11M	9M	10M
Pretax Income	4.28B	1.04B	2.67B	714M	1.55B	1.66B	-2.27B	2.08B	2.15B	1.76B	1.21B	1.95B	2.61B	475M	2.97B	4.4B	1.18B	4.93B	4.27B	3.69B	1.16B	3.87B
Net Income	3.61B	699M	1.82B	186M	938M	1.29B	-22M	1.56B	1.37B	1.37B	822M	1.78B	2.02B	239M	2.47B	3.95B	924M	4.49B	4.04B	3.18B	766M	3.55B
Selling & General & Admin	3.63B	3.58B	3.9B	3.57B	3.25B	3.29B	3.86B	4.21B	3.38B	3.32B	3.19B	3.37B	3.27B	3.04B	3.42B	3.3B	5.41B	3.13B	3.26B	3.08B	3.16B	2.84B
Research & Development	2.34B	2.47B	2.58B	2.32B	2.13B	2.07B	6.77B	2.13B	1.95B	1.94B	2.21B	1.72B	1.73B	2.29B	2.03B	1.65B	1.88B	1.64B	2.23B	2.06B	1.9B	1.85B
Other Expenses	291M	n/a	-217M	2.68B	799M	248M	1.57B	82M	937M	164M	n/a	66M	111M	140M	-1M	229M	-172M	n/a	n/a	500M	-68M	n/a
Operating Expenses	6.27B	6.05B	6.26B	8.57B	6.18B	5.61B	12.2B	6.42B	6.26B	5.42B	5.4B	5.16B	5.11B	5.47B	5.45B	5.19B	7.12B	4.77B	5.49B	5.65B	5B	4.69B
Interest Expense	746M	717M	714M	739M	740M	700M	702M	720M	726M	660M	564M	555M	552M	553M	566M	560M	556M	548M	580M	596M	615M	632M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	10.56B	10.27B	10.81B	13.87B	10.53B	9.61B	16.59B	10.63B	10.46B	9.51B	11.11B	11.65B	9.35B	9.46B	9.62B	10.21B	11.29B	8.82B	9.81B	10.04B	9.52B	8.91B
Income Tax Expense	662M	342M	853M	526M	613M	372M	-2.25B	520M	773M	383M	388M	172M	583M	234M	493M	448M	255M	436M	226M	508M	394M	312M
Shares Outstanding (Basic)	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B
Shares Outstanding (Diluted)	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.78B	1.78B	1.78B	1.78B	1.78B	1.78B	1.78B	1.78B	1.78B
EPS (Basic)	2.04	0.39	1.02	0.10	0.53	0.72	-0.02	0.88	0.77	0.77	0.46	1	1.14	0.13	1.40	2.23	0.52	2.54	2.29	1.78	0.42	2
EPS (Diluted)	2.04	0.39	1.02	0.10	0.53	0.72	-0.02	0.88	0.77	0.77	0.46	1	1.14	0.13	1.39	2.22	0.51	2.53	2.26	1.78	0.42	1.99
EBITDA	8.66B	3.69B	5.37B	3.52B	4.34B	4.4B	535M	4.88B	5B	4.49B	3.85B	4.74B	5.42B	3.16B	5.69B	7.17B	3.79B	7.53B	6.83B	6.41B	3.98B	6.71B
EBIT	6.72B	1.76B	3.38B	1.45B	2.29B	2.36B	-1.57B	2.8B	2.87B	2.42B	1.78B	2.51B	3.16B	1.03B	3.53B	4.96B	1.74B	5.48B	4.85B	4.28B	1.78B	4.5B
Depreciation & Amortization	1.94B	1.94B	1.99B	2.06B	2.05B	2.04B	2.1B	2.08B	2.13B	2.07B	2.08B	2.24B	2.26B	2.13B	2.16B	2.21B	2.05B	2.05B	1.98B	2.13B	2.2B	2.22B